SBIR-STTR Award

Next Generation Personal Protective Equipment for Real-time Inactivation of Airborne Biological Threats
Award last edited on: 6/2/2023

Sponsored Program
STTR
Awarding Agency
DOD : AF
Total Award Amount
$798,477
Award Phase
2
Solicitation Topic Code
AF21B-TCSO1
Principal Investigator
Richard Rasansky

Company Information

XCMR Inc

219 Righters Mill Road
Penn Valley, PA 19072
   (267) 237-6800
   N/A
   www.xcmr.co

Research Institution

University of Colorado - Boulder

Phase I

Contract Number: FA864922P0045
Start Date: 11/1/2021    Completed: 2/1/2022
Phase I year
2022
Phase I Amount
$49,974
XCMR is developing a safe and wearable, Far UV-C biodefense device that is highly effective at inactivating viruses, bacteria, and other airborne pathogens, thus providing a continuous "invisible" bubble of clean air supporting an airman's respiration. XC

Phase II

Contract Number: FA8649-22-P-1149
Start Date: 7/19/2022    Completed: 10/20/2023
Phase II year
2022
Phase II Amount
$748,503
XCMR is developing a safe and wearable, Far UV-C biodefense device that is highly effective at inactivating viruses, bacteria, and other airborne pathogens, thus providing a continuous "invisible" bubble of clean air supporting an airman's respiration. XCMR's Far UV-C (range between 221-223 nm with a peak at 222 nm) electromagnetic technology provides significant advantages over current UV germicidal light sources (254-280 nm) that have been used historically to disinfect surfaces and volumes of air but are harmful to humans. XCMR's development of a safe Far UV-C system is transformative and can be deployed in a broad range of military applications to protect against human exposure to airborne pathogens. XCMR’s modular technology provides superior protection against biological threats and pathogens in a variety of form factors that easily integrate into existing Mission Oriented Protective Postures (MOPP), safety, and communications equipment. Individual Airmen in operational and expeditionary environments, from pilots to maintainers to aeromedical evacuation personnel, will benefit from unencumbered protection against biological weapons and natural infectious disease threats.